Published in:

01-03-2000 | SHORT COMMUNICATION

Antiemetic efficacy of combination therapy with granisetron plus prednisolone plus the dopamine D₂ antagonist metopimazine during multiple cycles of moderately emetogenic chemotherapy in patients refractory to previous antiemetic therapy

Authors: T. Sigsgaard, J. Herrstedt, P. Christensen, O. Andersen, P. Dombernowsky

Published in: Supportive Care in Cancer | Issue 3/2000